Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 EUR | +0.33% | +1.68% | -35.33% |
May. 02 | Biotalys Starts Field Trials for Second Biofungicide | CI |
Apr. 30 | Biotalys Announces Board and Committee Changes | CI |
Sales 2024 * | 3M 3.27M | Sales 2025 * | 3M 3.27M | Capitalization | 96.79M 105M |
---|---|---|---|---|---|
Net income 2024 * | -11M -11.97M | Net income 2025 * | -12M -13.06M | EV / Sales 2024 * | 30.8 x |
Net cash position 2024 * | 4.4M 4.79M | Net Debt 2025 * | 9M 9.8M | EV / Sales 2025 * | 35.3 x |
P/E ratio 2024 * |
-7
x | P/E ratio 2025 * |
-2.51
x | Employees | 75 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.77% |
Latest transcript on Biotalys NV
1 day | +0.33% | ||
1 week | +1.68% | ||
Current month | +1.68% | ||
1 month | -2.58% | ||
3 months | -12.46% | ||
6 months | -9.04% | ||
Current year | -35.33% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin R. Helash
CEO | Chief Executive Officer | 59 | Nov. 30 |
Douglas Minder
DFI | Director of Finance/CFO | - | 20-12-31 |
Carlo Boutton
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 12-12-31 | |
Simon Moroney
CHM | Chairman | 65 | 21-03-31 |
Johan Cardoen
BRD | Director/Board Member | 65 | 12-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 3.02 | +0.33% | 330 |
24-06-06 | 3.01 | +0.67% | 12,524 |
24-06-05 | 2.99 | +0.34% | 26,260 |
24-06-04 | 2.98 | +0.34% | 12,057 |
24-06-03 | 2.97 | 0.00% | 6,075 |
Real-time Euronext Bruxelles, June 07, 2024 at 03:00 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.33% | 105M | |
-19.08% | 5.95B | |
+8.35% | 3.18B | |
+12.08% | 876M | |
-1.31% | 367M | |
+5.08% | 272M | |
+156.82% | 62.25M |
- Stock Market
- Equities
- BTLS Stock